細胞株開発の世界市場レポート 2025年

細胞株開発の市場規模は今後数年で急成長が見込まれます。2029年には複合年間成長率（CAGR）14.7％で163億3,000万米ドルに成長します。予測期間の成長は、がんの有病率の増加、慢性疾患の有病率の増加、ヘルスケアへの政府投資の増加に起因しています。予測期間における主な動向には、提携、投資、製品イノベーションなどがあります。

予想されるがん有病率の上昇が、当面の細胞株開発の成長を牽引します。がんは、体内の異常細胞の無秩序な増殖と拡散を特徴とする疾患群を指します。がん患者の増加は、主に人口増加、高齢化、ライフスタイルの選択、肥満、遺伝的素因などの要因によるものです。細胞株は、慢性疾患の治療に有効な薬剤をスクリーニングするための重要なツールです。研究者はこれらの細胞株を様々な化合物に暴露し、その効果を観察することで、さらなる開発のための有望な薬剤候補の同定を容易にしています。例えば、世界保健機関（WHO）が2024年2月に発表した報告書によると、新たながん患者数は2050年までに3,500万人以上に達すると予測され、2022年の推定2,000万人から77％増加します。このように、がんの有病率の増加は、細胞株開発市場の起爆剤となっています。

細胞株開発市場の主要プレーヤーは、競争優位性を獲得するために革新的なプラットフォームを積極的に追求しています。これらの革新的なプラットフォームは、細胞株開発プロセスを合理化・最適化し、生物学的医薬品の開発をサポートするスピード、効率性、生産性の向上を提供する能力によって際立っています。例えば、2023年1月、英国を拠点に研究・開発・製造のアウトソーシングサービスを提供するアブゼナ社は、生物学的製剤プログラムの細胞株開発（CLD）プロセスを加速するために設計された新しいプラットフォーム「AbZelect」および「AbZelectPro」を発表しました。これらのプラットフォームは生産性を向上させ、1回の製造工程でより多くの原薬を製造することを可能にします。この効率性の向上は、顧客の生産能力を拡大し、コストを削減するだけでなく、必要とする患者への重要な治療法の提供を迅速化します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界細胞株開発PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の細胞株開発市場：成長率分析
• 世界の細胞株開発市場の実績：規模と成長, 2019-2024
• 世界の細胞株開発市場の予測：規模と成長, 2024-2029, 2034F
• 世界細胞株開発総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の細胞株開発市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 試薬と培地
• 装置
• アクセサリーと消耗品
• 世界の細胞株開発市場：ソース別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 哺乳類
• 非哺乳類
• 世界の細胞株開発市場細胞株別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み換え
• ハイブリドーマ
• 常用細胞株
• 一次細胞株
• 世界の細胞株開発市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオプロダクション
• 創薬
• 毒性試験
• 組織工学
• 調査
• 世界の細胞株開発市場試薬と培地の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞培養培地
• 無血清培地
• 組み換えタンパク質サプリメント
• 成長因子
• サイトカインとホルモン
• 緩衝剤と塩
• 世界の細胞株開発市場、機器のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオリアクターと発酵槽
• インキュベーター
• 細胞カウンターと分析装置
• 細胞選別装置
• 凍結保存装置
• ろ過および分離装置
• 世界の細胞株開発市場アクセサリと消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 培養容器（フラスコ、プレート）
• ピペットとピペットチップ
• 細胞培養インサート
• 注射器と針
• クライオバイアルと凍結容器
• ペトリ皿

第7章 地域別・国別分析

• 世界の細胞株開発市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の細胞株開発市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 細胞株開発市場：競合情勢
• 細胞株開発市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • GE Health Care Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AGC Biologics
• Corning Inc.
• Eurofins Scientific
• Lonza Pvt. Ltd.
• WuXi App tech
• Sartorius AG
• GenScript Biotech Corporation
• FUJIFILM Diosynth Biotechnologies
• Promega corporation
• KBI Biopharma Inc.
• Rentschler Biopharma SE
• Advanced Instruments LLC
• Cyagen
• Horizon Discovery Group Plc
• Probiogen AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 細胞株開発市場2029：新たな機会を提供する国
• 細胞株開発市場2029：新たな機会を提供するセグメント
• 細胞株開発市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cell line development involves the creation of immortalized cell cultures derived from specific cell types, often originating from a particular organism or tissue. These cell lines are nurtured under controlled laboratory conditions and can be perpetually cultivated and reproduced.

The primary product types associated with cell line development include reagents and media, equipment, accessories, and consumables. Reagents and media encompass essential components utilized in laboratory settings for diverse biological and chemical analyses, experiments, and procedures. These components are sourced from various organisms, including mammalian and non-mammalian, and are utilized to generate different types of cell lines such as recombinant, hybridomas, continuous cell lines, and primary cell lines. Applications for these cell lines span bioproduction, drug discovery, toxicity testing, tissue engineering, and research endeavors.

The cell line development market research report is one of a series of new reports from The Business Research Company that provides cell line development market statistics, including cell line development industry global market size, regional shares, competitors with a cell line development market share, detailed cell line development market segments, market trends, and opportunities, and any further data you may need to thrive in the cell line development industry. This cell line development research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell line development market size has grown rapidly in recent years. It will grow from $8.21 billion in 2024 to $9.44 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased vaccine production, increased aging population, and increased clinical trials.

The cell line development market size is expected to see rapid growth in the next few years. It will grow to $16.33 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to increasing prevalence of cancer, increasing prevalence of chronic diseases, increasing government investments in healthcare. Major trends in the forecast period include partnerships, investments, and product innovations.

The anticipated rise in cancer prevalence is poised to drive the growth of cell line development in the foreseeable future. Cancer refers to a group of diseases characterized by the uncontrolled proliferation and spread of abnormal cells within the body. The increase in cancer cases is attributed primarily to factors such as population growth, aging, lifestyle choices, obesity, and genetic predisposition. Cell lines serve as crucial tools for screening potential drugs for their efficacy in treating chronic diseases. Researchers expose these cell lines to various compounds and observe their effects, facilitating the identification of promising drug candidates for further development. For instance, according to the World Health Organization's February 2024 report, the projected number of new cancer cases is expected to reach over 35 million by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Thus, the growing prevalence of cancer serves as a catalyst for the cell line development market.

Key players in the cell line development market are actively pursuing innovative platforms to gain a competitive advantage. These innovative platforms are distinguished by their ability to streamline and optimize the cell line development process, offering speed, efficiency, and enhanced productivity to support the development of biological drugs. For example, in January 2023, Abzena, a UK-based company providing outsourced research, development, and manufacturing services, introduced new platforms named AbZelect and AbZelectPro, designed to accelerate the cell line development (CLD) process for biologic drug programs. These platforms enhance productivity, enabling the production of greater quantities of drug substances per manufacturing run. This heightened efficiency not only expands capacity and reduces costs for customers but also expedites the delivery of critical therapies to patients in need.

In October 2022, Cytiva, a US-based life sciences company, acquired CEVEC Pharmaceuticals for an undisclosed sum. This acquisition bolsters Cytiva's capabilities in biomanufacturing solutions and supports the company's expansion in the genomic medicine sector. CEVEC Pharmaceuticals, headquartered in Germany, specializes in high-performance cell line development and viral vector manufacturing technologies.

Major companies operating in the cell line development market are Thermo Fisher Scientific Inc., Novartis AG, Danaher Corporation, Merck KGaA, GE Health Care, AGC Biologics, Corning Inc., Eurofins Scientific, Lonza Pvt. Ltd., WuXi App tech, Sartorius AG, GenScript Biotech Corporation, FUJIFILM Diosynth Biotechnologies, Promega corporation, KBI Biopharma Inc., Rentschler Biopharma SE, Advanced Instruments LLC, Cyagen, Horizon Discovery Group Plc, Probiogen AG, PromoCell GmbH, Premas Biotech, Imgenex, NAEJA RGM Pharmaceuticals Inc

North America was the largest region in the cell line development market in 2024. The regions covered in the cell line development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell line development market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell line development market consists of sales of primary cell lines, immortalized cell lines, stable cell lines, and clonal cell lines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Line Development Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell line development market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell line development ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell line development market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Reagents And Media; Equipment; Accessories And Consumables
• 2) By Source: Mammalian; Non-Mammalian
• 3) By Cell Line: Recombinant; Hybridomas; Continuous Cell Line; Primary Cell Line
• 4) By Application: Bioproduction; Drug Discovery; Toxicity Testing; Tissue Engineering; Research
• Subsegments:
• 1) By Reagents And Media: Cell Culture Media; Serum-Free Media; Recombinant Protein Supplements; Growth Factors; Cytokines And Hormones; Buffers And Salts
• 2) By Equipment: Bioreactors And Fermenters; Incubators; Cell Counters And Analyzers; Cell Sorters; Cryopreservation Equipment; Filtration And Separation Equipment
• 3) By Accessories And Consumables: Culture Vessels (Flasks, Plates); Pipettes And Pipette Tips; Cell Culture Inserts; Syringes And Needles; Cryovials And Freezing Containers; Petri Dishes
• Companies Mentioned: Thermo Fisher Scientific Inc.; Novartis AG; Danaher Corporation; Merck KGaA; GE Health Care
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Line Development Market Characteristics

3. Cell Line Development Market Trends And Strategies

4. Cell Line Development Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cell Line Development Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cell Line Development PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cell Line Development Market Growth Rate Analysis
• 5.4. Global Cell Line Development Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cell Line Development Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cell Line Development Total Addressable Market (TAM)

6. Cell Line Development Market Segmentation

• 6.1. Global Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Media
• Equipment
• Accessories And Consumables
• 6.2. Global Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mammalian
• Non-Mammalian
• 6.3. Global Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant
• Hybridomas
• Continuous Cell Line
• Primary Cell Line
• 6.4. Global Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioproduction
• Drug Discovery
• Toxicity Testing
• Tissue Engineering
• Research
• 6.5. Global Cell Line Development Market, Sub-Segmentation Of Reagents And Media, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Culture Media
• Serum-Free Media
• Recombinant Protein Supplements
• Growth Factors
• Cytokines And Hormones
• Buffers And Salts
• 6.6. Global Cell Line Development Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioreactors And Fermenters
• Incubators
• Cell Counters And Analyzers
• Cell Sorters
• Cryopreservation Equipment
• Filtration And Separation Equipment
• 6.7. Global Cell Line Development Market, Sub-Segmentation Of Accessories And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Culture Vessels (Flasks, Plates)
• Pipettes And Pipette Tips
• Cell Culture Inserts
• Syringes And Needles
• Cryovials And Freezing Containers
• Petri Dishes

7. Cell Line Development Market Regional And Country Analysis

• 7.1. Global Cell Line Development Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cell Line Development Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell Line Development Market

• 8.1. Asia-Pacific Cell Line Development Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell Line Development Market

• 9.1. China Cell Line Development Market Overview
• 9.2. China Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell Line Development Market

• 10.1. India Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell Line Development Market

• 11.1. Japan Cell Line Development Market Overview
• 11.2. Japan Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell Line Development Market

• 12.1. Australia Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell Line Development Market

• 13.1. Indonesia Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell Line Development Market

• 14.1. South Korea Cell Line Development Market Overview
• 14.2. South Korea Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell Line Development Market

• 15.1. Western Europe Cell Line Development Market Overview
• 15.2. Western Europe Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell Line Development Market

• 16.1. UK Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell Line Development Market

• 17.1. Germany Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell Line Development Market

• 18.1. France Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell Line Development Market

• 19.1. Italy Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell Line Development Market

• 20.1. Spain Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell Line Development Market

• 21.1. Eastern Europe Cell Line Development Market Overview
• 21.2. Eastern Europe Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell Line Development Market

• 22.1. Russia Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell Line Development Market

• 23.1. North America Cell Line Development Market Overview
• 23.2. North America Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell Line Development Market

• 24.1. USA Cell Line Development Market Overview
• 24.2. USA Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell Line Development Market

• 25.1. Canada Cell Line Development Market Overview
• 25.2. Canada Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell Line Development Market

• 26.1. South America Cell Line Development Market Overview
• 26.2. South America Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell Line Development Market

• 27.1. Brazil Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell Line Development Market

• 28.1. Middle East Cell Line Development Market Overview
• 28.2. Middle East Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell Line Development Market

• 29.1. Africa Cell Line Development Market Overview
• 29.2. Africa Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell Line Development Market Competitive Landscape And Company Profiles

• 30.1. Cell Line Development Market Competitive Landscape
• 30.2. Cell Line Development Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GE Health Care Overview, Products and Services, Strategy and Financial Analysis

31. Cell Line Development Market Other Major And Innovative Companies

• 31.1. AGC Biologics
• 31.2. Corning Inc.
• 31.3. Eurofins Scientific
• 31.4. Lonza Pvt. Ltd.
• 31.5. WuXi App tech
• 31.6. Sartorius AG
• 31.7. GenScript Biotech Corporation
• 31.8. FUJIFILM Diosynth Biotechnologies
• 31.9. Promega corporation
• 31.10. KBI Biopharma Inc.
• 31.11. Rentschler Biopharma SE
• 31.12. Advanced Instruments LLC
• 31.13. Cyagen
• 31.14. Horizon Discovery Group Plc
• 31.15. Probiogen AG

32. Global Cell Line Development Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Line Development Market

34. Recent Developments In The Cell Line Development Market

35. Cell Line Development Market High Potential Countries, Segments and Strategies

• 35.1 Cell Line Development Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cell Line Development Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cell Line Development Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer